SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Laertes Manuelidis who wrote (416)2/15/1997 6:06:00 PM
From: John Chylek   of 2742
 
Layman, or anyone, help me out. The $.42p/share is cash, not earnings, and thus the standard PE formulas do not apply; that is, if CIST had a PE of 10 @ $.42 its value would be $4.20. What do you estimate the burn rate of this cash will be? Also, would it be true to say that if the future earnings p/qtr equal the cash burn p/qrtr that the value would indeed be $4.20 (PE 10)? Any thoughts on how they will distribute the cast between R&D, marketing, etc. Hopefully, that kind of info will be in PR piece next week. CIST now has an asset base of $12M...that's alot of bunson burners.

I'm starting to think long term on this stock.
John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext